The Pro12Ala polymorphism in PPAR γ2 may confer resistance to type 2 diabetes

Biochemical and Biophysical Research Communications

Volumn 271, Issue 1, 2000, Pages 212-216

  Hara, Kazuo ^a,b   Okada, Terumasa ^b   Tobe, Kazuyuki ^b   Yasuda, Kazuki ^c   Mori, Yasumichi ^b   Kadowaki, Hiroko ^a   Hagura, Ryoko ^a   Akanuma, Yasuo ^a   Kimura, Satoshi ^b   Ito, Chikako ^d   Kadowaki, Takashi ^b  

^a INSTITUTE FOR ADULT DISEASES   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c CHIBA UNIVERSITY   (Japan)

^d Health Management and Promotion Center   (Japan)

Author keywords

Insulin resistance; Peroxisome proliferator activated receptor ; Pro12Ala polymorphism; Thrifty gene; Type 2 diabetes

Indexed keywords

PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR;

ADIPOCYTE; AMINO ACID SUBSTITUTION; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; HOST RESISTANCE; HUMAN; INSULIN RESISTANCE; LIPID DIET; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL;

ANIMALIA;

EID: 0034728762     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1006/bbrc.2000.2605     Document Type: Article

References (17)

1. Tontonoz, P., Hu, E., and Spiegelman, B. M. (1994) Stimulation of adipogenesis in fibroblasts by PPARγ2, a lipid-activated transcription factor. Cell 79, 1147-1156.
2. Lehmann, J. M., Moore, L. B., Smith-Oliver, T. A., Wilkinson, W. O., Willson, T. M., and Kliewer, S. A. (1995) An antidiabetic thiazolidinedione is a higher affinity ligand for peroxisome proliferator-activated receptor-γ. J. Biol. Chem. 272, 18779-18789.
3. Kubota, N., Terauchi, Y., Miki, H., Tamemoto, H., Yamauchi, T., Komeda, K., Satoh, S., Nakano, R., Ishii, C., Sugiyama, T., Eto, K., Tsubamoto, Y., Okuno, A., Murakami, K., Sekihara, H., Hasegawa, G., Naito, M., Toyoshima, Y., Tanaka, S., Shiota, K., Kitamura, T., Fujita, T., Ezaki, O., Aizawa, S., Kadowaki, T. et al. (1999) PPARγ mediates high-fat diet-induced adipocyte hypertrophy and insulin resistance. Molecular Cell 4, 597-609.
4. Auwerx, J. (1999) PPARγ, the ultimate thrifty gene. Diabetologia 42, 1033-1049.
5. Yen, C. J., Beamer, B. A., Negri, C., Silver, K., Brown, K. A., Yarnall, D. P., Burns, D. K., Roth, J., and Shuldiner, A. R. (1997) Molecular scanning of the human peroxisome proliferator activated receptor γ (hPPARγ) gene in diabetic Caucasians: Identification of a Pro12Ala PPAR γ 2 missense mutation. Biochem. Biophys. Res. Commun. 241, 270-274, doi:10.1006/bbrc.1997.7798.
6. Werman, A., Hollenberg, A., Solanes, G., Bjorbaek, C., Vidal-Puig, A. J., and Flier, J. S. (1997) Ligand-independent activation domain in the N-terminus of peroxisome proliferator-activated receptor γ: Differential activity of PPARγ-1 and -2 isoforms and influence of insulin. J. Biol Chem. 272, 20230-20235.
7. Deeb, S. S., Fajas, L., Nemoto, M., Pihlajamaki, J., Mykkanen, L., Kuusisto, J., Laakso, M., Fujimoto, W., and Auwerx, J. (1998) A Pro12Ala substitution in PPARγ2 associated with decreased receptor activity, lower body mass index, and improved insulin sensitivity. Nat. Genet. 20, 284-287.
8. Matthews, D. R., Rudenski, A. S., Naylor, B. A., Treacher, D. F., and Turner, R. C. (1985) Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28, 412-419.
9. Mori, Y., Motoyama, H. K., Katakura, T., Yasuda, K., Kadowaki, H., Beamer, B. A., Shuldiner, A. R., Akanuma, Y., Yazaki, Y., and Kadowaki, T. (1998) Effect of the Pro12Ala variant of the human peroxisome proliferator-activated receptor γ2 gene on adiposity, fat distribution, and insulin sensitivity in Japanese men. Biochem. Biophys. Res. Commun. 251, 195-198, doi: 10.1006/bbrc.1998.9421.
10. Bonora, E., Saggiani, F., Targher, G., Zenere, M. B., Alberiche, M., Monauni, T., Bonadonna, R. C., and Muggeo, M. (2000) Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity. Diabetes Care 23, 57-63.
11. Flegal, K. M., Carroll, M. D., Kuczmarski, R. J., and Johnson, C. L. (1998) Overweight and obesity in the United States: Prevalence and trends, 1960-1994. Int. J. Obes. Relat. Metab. 22, 39-47.
12. Ringel, J., Engeli, S., Distler, A., and Sharma, A. M. (1999) Pro12Ala missense mutation of the peroxisome proliferator activated receptor γ2 and diabetes mellitus. Biochem. Biophys. Res. Commun. 254, 450-453, doi:10.1006/bbrc.1998.9962.
13. Mancini, F. P., Vaccaro, O., Sabatino, L., Tufano, A., Rivellese, A. A., Riccardi, G., and Colantuoni, V. (1999) Pro12Ala substitution in the peroxisome proliferator-activated receptor-γ2 is not associated with type 2 diabetes. Diabetes 48, 1466-1468.
14. Beamer, B. A., Yen, C. J., Andersen, R. E., Muller, D., Elahi, D., Cheskin, L. J., Andres, R., Roth, J., and Shuldiner, A. R. (1998) Association of the Pro12Ala variant in the peroxisome proliferator-activate receptor-γ2 gene with obesity in two Caucasian populations. Diabetes 47, 1806-1808.
15. Ek, J., Urhammer, S. A., Sorensen, T. I., Andersen, T., Auwerx, J., and Pederson, O. (1999) Homozygosity of the Pro12Ala variant of the peroxisome proliferation-activated receptor γ2 (PPARγ2): Divergent modulating effects on body mass index in obese and lean Caucasian men. Diabetologia 42, 892-895.
16. Kallen, C. B., and Lazar, M. A. (1996) Antidiabetic thiazolidinediones inhibit leptin(ob) gene expression in 3T3-L1 adipocytes. Proc. Natl. Acad. Sci. USA 93, 5397-5396.
17. Hollenberg, A. N., Susulic, V. S., Madura, J. P., Zhang, B., Moller, D. E., Tontonoz, P., Saraf, P., Spiegelman, B. M., and Lowell, B. B. (1997) Functional antagonism between CCAAT/ enhancer binding protein-a and peroxisome proliferator-activated receptor-γ on the leptin promoter. J. Biol. Chem. 21, 5283-5290.